---
title: "CSPC PHARMA  Receives USD30 million Upfront Payment From AstraZeneca"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295682965.md"
description: "CSPC PHARMA-0.025 (-0.287%) Short selling $105.02M; Ratio 23.941% announced that on August 12, it received a USD30 million upfront payment from AstraZeneca under the siRNA drug development collaboration, option and licensing agreement, marking the smooth progress of the cooperation between the two parties. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-12 16:25.)"
datetime: "2026-08-12T15:06:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295682965.md)
  - [en](https://longbridge.com/en/news/295682965.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295682965.md)
---

# CSPC PHARMA  Receives USD30 million Upfront Payment From AstraZeneca

CSPC PHARMA (01093.HK) \-0.025 (-0.287%) Short selling $105.02M; Ratio 23.941% announced that on August 12, it received a USD30 million upfront payment from AstraZeneca under the siRNA drug development collaboration, option and licensing agreement, marking the smooth progress of the cooperation between the two parties. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-12 16:25.)

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [CSPC Pharmaceutical receives USD 30 million upfront payment from AstraZeneca under siRNA pact](https://longbridge.com/en/news/295663654.md)
- [AstraZeneca halts lung cancer trial of volrustomig in latest blow to pipeline](https://longbridge.com/en/news/296069146.md)
- [AstraZeneca Reports Mixed Lung Cancer Trial Outcomes From Three Pivotal Studies](https://longbridge.com/en/news/296114723.md)
- [CSPC Pharmaceutical changes trustee for 2018 share award scheme to BOCI Trustee Hong Kong](https://longbridge.com/en/news/295684438.md)
- [Ascent Group LLC Has $3.21 Million Stake in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/295994083.md)